The CAM Model—Q&A with Experts

Fischer D, Fluegen G, Garcia P, Ghaffari-Tabrizi-Wizsy N, Gribaldo L, Huang RYJ, Rasche V, Ribatti D, Rousset X, Pinto MT, Viallet J, Wang Y, Schneider-Stock R (2023)


Publication Type: Journal article, Review article

Publication year: 2023

Journal

Book Volume: 15

Article Number: 191

Journal Issue: 1

DOI: 10.3390/cancers15010191

Abstract

The chick chorioallantoic membrane (CAM), as an extraembryonic tissue layer generated by the fusion of the chorion with the vascularized allantoic membrane, is easily accessible for manipulation. Indeed, grafting tumor cells on the CAM lets xenografts/ovografts develop in a few days for further investigations. Thus, the CAM model represents an alternative test system that is a simple, fast, and low-cost tool to study tumor growth, drug response, or angiogenesis in vivo. Recently, a new era for the CAM model in immune-oncology-based drug discovery has been opened up. Although there are many advantages offering extraordinary and unique applications in cancer research, it has also disadvantages and limitations. This review will discuss the pros and cons with experts in the field.

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Fischer, D., Fluegen, G., Garcia, P., Ghaffari-Tabrizi-Wizsy, N., Gribaldo, L., Huang, R.Y.J.,... Schneider-Stock, R. (2023). The CAM Model—Q&A with Experts. Cancers, 15(1). https://dx.doi.org/10.3390/cancers15010191

MLA:

Fischer, Dagmar, et al. "The CAM Model—Q&A with Experts." Cancers 15.1 (2023).

BibTeX: Download